Sign in
Taking peopleNo phase

Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation

Key facts

Who runs it
Zhongnan Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
110 people, planned
Started
6 Mar 2026
Expected to end
1 May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intrapulmonary percussion ventilation
  • usual care
Record updated
12 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Meeting the diagnostic criteria for pulmonary infection, defined as follows: meeting the diagnostic criteria for hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) according to the Chinese Guidelines for the Diagnosis and Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults (2018 edition), or meeting the diagnostic criteria for community-acquired pneumonia (CAP) according to the Chinese Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia in Adults (2016 edition)
  • Oxygenation index (PaO₂/FiO₂) ≤ 300
  • Currently receiving invasive mechanical ventilation, with no planned liberation from invasive mechanical ventilation within the next 24 hours
  • Receiving analgesia and sedation
  • Written informed consent provided by the patient's family member or legally authorized representative

Who cannot take part

  • Unstable chest wall, flail chest, recent thoracic or airway surgery, or severe thoracic spine injury
  • Inability to place the EIT chest belt, such as open thoracic surgical wounds or skin lesions at the belt placement site
  • Receiving extracorporeal membrane oxygenation (ECMO)
  • Concurrent participation in another clinical trial
  • Markedly elevated intracranial pressure (> 25 mmHg) or a condition requiring strict intracranial pressure control
  • Acute exacerbation of chronic obstructive pulmonary disease as the primary reason for the current episode of invasive mechanical ventilation
  • Presence of severe hemodynamic instability (norepinephrine dose > 0.5 μg/kg/min)
  • Severe pulmonary bullae, untreated tension pneumothorax or undrained mediastinal emphysema
  • Active massive hemoptysis
  • Severe bronchospasm or inability to tolerate fluctuations in airway pressure
  • Expected death within 24 hours, or a decision already made to withhold or withdraw life-sustaining treatment
  • Pregnancy or breastfeeding

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether adding intrapulmonary percussion ventilation (IPV) to standard airway clearance treatment improves clinical outcomes in invasively mechanically ventilated patients with pulmonary infection. It will also evaluate the safety of IPV in this population and assess changes in lung ventilation using electrical impedance tomography (EIT).

Read full original descriptionShow less

The main questions it aims to answer are:

Does adding IPV shorten the duration of invasive mechanical ventilation compared with standard therapy alone? Does IPV improve regional and global lung ventilation? Does IPV improve clinical indicators, including oxygenation, lung mechanics, and pulmonary infection scores? Is IPV safe in mechanically ventilated patients with pulmonary infection?

Participants will:

Receive either standard therapy alone or standard therapy plus IPV Undergo serial EIT monitoring at predefined time points Receive routine clinical assessments and ventilator parameter monitoring during ICU stay Be followed until successful weaning, discharge, or completion of hospitalization

The 2 groups in the trial

  • Intrapulmonary percussion ventilationTreatment being tested

    Treatment: Intrapulmonary percussion ventilation and usual care

  • usual careExisting treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation Assessed by Electrical Impedance Tomography: a Randomized Controlled Trial
Record updated
12 August 2026